Actinium Pharmaceuticals, Inc. (ATNM)

Latest Insider Confidence Score

2025Q4

49.7
Bearish

Company insider confidence (by quarter)

2007Q1 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Button Diane S — 20,000,000 Feb 7, 2007
AHLB Holdings, LLC — 5,702,387 May 8, 2015
Actinium Holdings, Ltd. — 5,702,387 May 8, 2015
Memorial Sloan-Kettering Cancer Center 10% Owner 4,709,561 Sep 1, 2016
Kapur Anil — 400,000 Jul 16, 2019

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 18, 2025 Aug 20, 2025 SETH SANDESH CEO Sell 42.5 -120,900 -39.59% ✗ $206.7K
Mar 31, 2025 Apr 2, 2025 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Almenoff June Sherie Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 O'Loughlin Steve CFO Neutral 52.5 - 0.00% ✗ -
Nov 1, 2024 Nov 5, 2024 Almenoff June Sherie Director Neutral 52.5 - 0.00% ✗ -
Nov 5, 2024 Almenoff June Sherie Director Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 O'Loughlin Steve CFO Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Dec 28, 2023 Dec 29, 2023 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Aug 17, 2022 Aug 19, 2022 SETH SANDESH CEO Neutral 90.0 +300,000 5575.17% ✗ -
Jul 1, 2022 Jul 1, 2022 O'Loughlin Steve CFO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 1, 2022 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 1, 2022 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 1, 2022 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 1, 2022 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 1, 2022 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 O'Loughlin Steve CFO Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Sep 1, 2021 Sep 3, 2021 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 O'Loughlin Steve CFO Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Ludwig Dale L. Chief Science & Tech. Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2020 Aug 14, 2020 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Ludwig Dale L. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 O'Loughlin Steve Principal Financial Officer Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Kapur Anil Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2019 Jul 16, 2019 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2019 Mar 7, 2019 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 21, 2019 Feb 21, 2019 SETH SANDESH CEO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2018 Dec 10, 2018 SETH SANDESH CEO Buy 85.0 +10,000 6.98% ✗ $4.4K
Dec 10, 2018 Dec 10, 2018 O'Loughlin Steve Principal Financial Officer Buy 90.0 +10,000 39.22% ✗ $4.4K
Nov 19, 2018 Nov 20, 2018 Ludwig Dale L. Chief Scientific Officer Buy 90.0 +10,000 100.00% ✗ $4.5K
Jul 13, 2018 Jul 17, 2018 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Jul 13, 2018 Jul 17, 2018 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Jul 13, 2018 Jul 17, 2018 Ray Nitya G. Executive VP Neutral 52.5 - 0.00% ✗ -
Jul 13, 2018 Jul 17, 2018 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 17, 2018 Jul 17, 2018 SETH SANDESH CEO Buy 85.0 +10,000 7.50% ✗ $7.9K
Jul 13, 2018 Jul 17, 2018 O'Loughlin Steve Principal Financial Officer Neutral 52.5 - 0.00% ✗ -
Jul 13, 2018 Jul 17, 2018 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Jul 13, 2018 Jul 17, 2018 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2018 Jun 15, 2018 O'Loughlin Steve Principal Financial Officer Buy 90.0 +12,000 88.89% ✗ $6K
May 1, 2018 Chell Jeffrey W. Director Neutral 52.5 - 0.00% ✗ -
Apr 19, 2018 Apr 20, 2018 SETH SANDESH CEO Buy 82.5 +5,000 3.90% ✗ $1.9K
Mar 6, 2018 Mar 19, 2018 Berger Mark Stanley Chief Medical Officer Buy 90.0 +14,000 280.00% ✗ $7K
Mar 6, 2018 Mar 8, 2018 SETH SANDESH CEO Buy 91.3 +52,500 69.23% ✗ $26.3K
Mar 6, 2018 Mar 8, 2018 Ray Nitya G. Executive VP Buy 90.0 +10,000 100.00% ✗ $5K
Mar 6, 2018 Mar 8, 2018 Steinhart Richard I Director Buy 90.0 +7,000 280.00% ✗ $3.5K
Mar 6, 2018 Mar 8, 2018 O'Loughlin Steve Principal Financial Officer Buy 90.0 +10,000 285.71% ✗ $5K
Feb 28, 2018 Mar 1, 2018 Shetty Ajit Director Buy 90.0 +22,730 100.00% ✗ $9.8K
Feb 8, 2018 Kapur Anil Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 9, 2018 Ludwig Dale L. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 2, 2017 Aug 4, 2017 SETH SANDESH CEO Buy 91.3 +33,333 78.43% ✗ $25K
Aug 2, 2017 Aug 4, 2017 Ray Nitya G. President Buy 90.0 +10,000 100.00% ✗ $7.5K
Jun 19, 2017 Ray Nitya G. President Neutral 52.5 - 0.00% ✗ -
Jun 15, 2017 Jun 15, 2017 Berger Mark Stanley Chief Medical Officer Buy 90.0 +5,000 100.00% ✗ $5.6K
Jun 15, 2017 Jun 15, 2017 SETH SANDESH CEO Buy 90.0 +7,500 10.34% ✗ $8.7K
Jun 15, 2017 Jun 15, 2017 O'Loughlin Steve Principal Financial Officer Buy 90.0 +3,500 100.00% ✗ $4.1K
May 17, 2017 O'Loughlin Steve VP, Finance and Corporate Dev. Neutral 52.5 - 0.00% ✗ -
Mar 28, 2017 Shetty Ajit Director Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 DAVE KAUSHIK J CEO Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 SETH SANDESH Chair Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 TRAVERSA SERGIO Director Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 Nicholson, C. David Director Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 Steinhart Richard I Director Neutral 52.5 - 0.00% ✗ -
Mar 14, 2017 Mar 16, 2017 CICIC DRAGAN Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Mar 16, 2017 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 30, 2016 Jan 3, 2017 SETH SANDESH Chair Buy 90.0 +5,000 16.67% ✗ $4.4K
Dec 12, 2016 Dec 12, 2016 SETH SANDESH Chair Buy 90.0 +5,000 20.00% ✗ $4.9K
Aug 30, 2016 Sep 1, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 20.0 -192,927 -3.94% ✗ $352.4K
Aug 26, 2016 Aug 30, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 22.5 -50,000 -1.01% ✗ $85.5K
Aug 15, 2016 Aug 17, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 51.3 -9,468 -0.19% ✗ $16.3K
Jul 12, 2016 Jul 14, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 52.5 -3,100 -0.06% ✗ $5.6K
Jul 8, 2016 Jul 12, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 43.8 -21,990 -0.44% ✗ $39.6K
Jul 5, 2016 Jul 7, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 43.8 -20,840 -0.42% ✗ $37.8K
Jun 30, 2016 Jul 5, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 45.0 -148,100 -0.12% ✗ $268.4K
Jun 15, 2016 Jun 17, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 32.5 -33,619 -0.65% ✗ $63.9K
Jun 2, 2016 Jun 6, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 43.8 -17,790 -0.34% ✗ $35.7K
May 31, 2016 Jun 2, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 20.0 -169,450 -3.15% ✗ $333.4K
May 26, 2016 May 31, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 32.5 -40,068 -0.74% ✗ $77.1K
May 25, 2016 May 26, 2016 Memorial Sloan-Kettering Cancer Center 10% Owner Sell 32.5 -36,400 -0.67% ✗ $69.2K